ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Annexon Biosciences
The Executive Director & Head Clinical Data Management leads a team of data managers and technology experts overseeing acquisition and quality of all clinical trial data at Annexon Biosciences. Reporting to the SVP of Biometrics, this senior leader sets vision, provides strategic and technical direction, and ensures delivery of high‑quality data throughout study lifecycles.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2011
Annexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Annexon Biosciences.
52% above the average for this role
Annexon Biosciences stock rating reiterated by Cantor Fitzgerald
Jan 14, 2026
